A journal article was submitted that documented a study where off-shelf devices were used for treatment of thoracic aortic diseases.Retrospective analysis was conducted of 474 consecutive patients treated with either fenestration tevar (f-tevar) or chimney tevar (ch-tevar).The complete se stents were only implanted in patients in the f-tevar group.The primary endpoints at 30 days and during follow up were overall mortality, aorta-related mortality, and major complications.The secondary endpoints were endoleak and reintervention.It was reported that 4 patients died within 30 days of procedures.One patient with tad suffered a retrograde dissection which resulted in death on the third day.Of the three deaths among the 364 ch-tevar patients, one was due to cerebral infarction 3 days post procedure, another to retrograde dissection at 2 days and third to myocardial infaction 4 days post tevar.Perioperative cerebral ischemia occurred in nine patients: 1 f-tevar patient had a tia with full recovery in follow up vs 7tias in ch-tevar group (all treated and discharged), in addition to the fatal stroke noted above.Two f-tevar patients died of retrograde dissection at 8 and 16 months in addition to the one in hospital.In the ch-tevar group, 7 patients died at follow up in addition to the fatal retrograde dissection in hospital.Of these 7 late deaths, 2 were sudden deaths after complaining about chest tightness and uncontrollable hypertension that was believed to be related to tad.One patient died of acute cerebral infarction, 3 patients died of retrograde dissection af ter open surgery, and one patient died of pulmonary infection subsequent to paraplegia.During entire follow up period, 22 patients suffered cerebral ischemia (4 in f-tevar group and 18 in the ch-tevar group).Stent migration and retrograde dissection occurred in 11 and 13 of all patients respectively, without significant differences between treatment approaches.36 patients underwent reintervention for proximal type i endoleak.One hundred of the 593 branch stents occluded.Of the 62 patients with branch occlusion, 28 were asymptomatic, and no reintervention performed.As of the bare metal stents used in f-tevar, the majority (26/27) were patent.
|